228 related articles for article (PubMed ID: 11266848)
1. Proliferative responses to allogeneic HLA class I peptides.
Paraoan MT; Sells RA; Bakran A; Hammad A; Christmas SE
Transplant Proc; 2001; 33(1-2):334-5. PubMed ID: 11266848
[No Abstract] [Full Text] [Related]
2. Human leukocyte antigen-class II-positive human corneal epithelial cells activate allogeneic T cells.
Iwata M; Yagihashi A; Roat MI; Zeevi A; Iwaki Y; Thoft RA
Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):3991-4000. PubMed ID: 7960581
[TBL] [Abstract][Full Text] [Related]
3. [The immune response to kidney allograft. Part I: the role of MHC antigens, antigen-presenting cells, and lymphocytes in alloantigen recognition; two-signal activation of T cells].
Kusztal M; Jezior D; Weyde W; Krajewska M; Klinger M
Postepy Hig Med Dosw (Online); 2007; 61():13-20. PubMed ID: 17245313
[TBL] [Abstract][Full Text] [Related]
4. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.
Germain RN
Cell; 1994 Jan; 76(2):287-99. PubMed ID: 8293464
[No Abstract] [Full Text] [Related]
5. From antigen presentation to T-cell activation.
Lanzavecchia A
Res Immunol; 1998; 149(7-8):626. PubMed ID: 9851512
[No Abstract] [Full Text] [Related]
6. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
Clement JD; Chan SY; Bishop DK
Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688
[TBL] [Abstract][Full Text] [Related]
7. MHC restriction of T-cell proliferative responses in Xenopus.
Harding FA; Flajnik MF; Cohen N
Dev Comp Immunol; 1993; 17(5):425-37. PubMed ID: 7505753
[TBL] [Abstract][Full Text] [Related]
8. A speculative view of the multicomponent nature of T cell antigen recognition.
Goverman J; Hunkapiller T; Hood L
Cell; 1986 May; 45(4):475-84. PubMed ID: 3085952
[No Abstract] [Full Text] [Related]
9. Minors come of age: Minor histocompatibility antigens and graft-versus-host disease.
Chao NJ
Biol Blood Marrow Transplant; 2004 Apr; 10(4):215-23. PubMed ID: 15077220
[TBL] [Abstract][Full Text] [Related]
10. Host T-cell primary allosensitization to MHC class-I- and class-II-expressing human cardiac myocytes requires the presence of a second signal.
Ansari AA; Wang YC; Kanter K; Villinger F; Mayne A; Sell KW; Herskowitz A
Hum Immunol; 1993 Jun; 37(2):108-18. PubMed ID: 8226137
[TBL] [Abstract][Full Text] [Related]
11. Antigen presentation and T cell development in H2-M-deficient mice.
Fung-Leung WP; Surh CD; Liljedahl M; Pang J; Leturcq D; Peterson PA; Webb SR; Karlsson L
Science; 1996 Mar; 271(5253):1278-81. PubMed ID: 8638109
[TBL] [Abstract][Full Text] [Related]
12. Class I antigen presentation.
Jelachich ML; Biddison WE
Year Immunol; 1989; 4():41-58. PubMed ID: 2522701
[No Abstract] [Full Text] [Related]
13. T-cell allorecognition of HLA class II.
Termijtelen A
Hum Immunol; 1990 May; 28(1):1-10. PubMed ID: 2187838
[No Abstract] [Full Text] [Related]
14. Direct and indirect recognition: the role of MHC antigens in graft rejection.
Gould DS; Auchincloss H
Immunol Today; 1999 Feb; 20(2):77-82. PubMed ID: 10098326
[TBL] [Abstract][Full Text] [Related]
15. Hypothesis for autoantigen presentation and T cell activation.
Mircheff AK; Gierow JP; Wood RL; Akashi RH; Hofman FM
Adv Exp Med Biol; 1994; 350():651-4. PubMed ID: 8030550
[No Abstract] [Full Text] [Related]
16. The antigen-presenting function of human Langerhans cells.
Braathen LR; Bjercke S; Thorsby E
Immunobiology; 1984 Dec; 168(3-5):301-12. PubMed ID: 6241602
[No Abstract] [Full Text] [Related]
17. Major histocompatibility antigen class II expressing resting porcine T lymphocytes are potent antigen-presenting cells in mixed leukocyte culture.
Saalmüller A; Maurer S
Immunobiology; 1994 Feb; 190(1-2):23-34. PubMed ID: 8082885
[TBL] [Abstract][Full Text] [Related]
18. Regulation of lymphokine release involving a novel form of T-T collaboration.
Gill RG; Lafferty KJ
Transplant Proc; 1989 Feb; 21(1 Pt 3):2700-2. PubMed ID: 2495673
[No Abstract] [Full Text] [Related]
19. Antigen presentation to cytotoxic T lymphocytes in vivo.
Bevan MJ
J Exp Med; 1995 Sep; 182(3):639-41. PubMed ID: 7650475
[No Abstract] [Full Text] [Related]
20. Cyclosporine A inhibition of alloantigen presentation.
Little RG; Ebertowski LA; David CS
Transplant Proc; 1991 Apr; 23(2 Suppl 2):6-9. PubMed ID: 1829555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
